DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
201 hedge funds and large institutions have $1.14B invested in DIPLOMAT PHARMACY, INC. in 2018 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 63 increasing their positions, 73 reducing their positions, and 35 closing their positions.
18% more capital invested
Capital invested by funds: $960M → $1.14B (+$177M)
9% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 35
2% more call options, than puts
Call options by funds: $3.94M | Put options by funds: $3.88M
1% more funds holding
Funds holding: 200 → 201 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 73
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$118M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.5M |
| 4 |
RI
Redwood Investments
Boston,
Massachusetts
|
+$19.4M |
| 5 |
Millennium Management
New York
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
-$30.7M |
| 2 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$15M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$11.5M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$11.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$7.04M |
DPLO Hedge Fund Activity: Q1 2018 in Review
201 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2018, worth a combined $1.14B — up 18% from $960M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new DPLO positions and 35 closed out — a net gain of 3 holders — while 63 added to existing stakes and 73 trimmed.
The largest buyer was Capital World Investors, adding an estimated $118M. The largest seller was Davis Selected Advisers, cutting an estimated $30.7M.
- 201 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2018, up from 200 in Q4 2017.
- Funds reported $1.14B of DIPLOMAT PHARMACY, INC. stock for Q1 2018, up 18% quarter-over-quarter.
- 38 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2018 and 35 closed out, a net change of +3 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q1 2018 was Capital World Investors, an estimated $118M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q1 2018 was Davis Selected Advisers, an estimated $30.7M sold.
Based on aggregated 13F filings for Q1 2018.